The Japanese Journal of Ophthalmology accepts original papers on clinical as well as basic investigations of physiology and pathology of the eye and related organs and systems. Research involving human subjects should comply with Declaration of Helsinki of the World Medical Association. Masuscripts should contain the statement that signed informed consent froms have been obtained from all study subjects. Documents showing approval by the institutional review board or an equivalent authority should be submitted with manuscripts. In addition to original full length articles authors may submit review articles, brief communications (which are concise articles of 1,500 words or less on research supported by limited but significant data) , case reports and letters. Only articles not previously published, except as abstracts, are accepted. It is also understood that articles will not be submitted elsewhere while being reviewed by the Japanese Journal of Ophthalmology. Peer-review will be accorded all submitted papers. Most will be reviewed by two or more members of the editorial board or specially qualified outside reviewers. Reviews will be conducted anonymously, with the reviewers not knowing the names of authors. The Editor-in Chief's decisions will be final. All submitted material will be subject to copyediting. Before publication, page proofs will be forwarded to the designated author who will bear responsibility for the final manuscript contents, including all copyediting changes.
Conflict of Interest Policy
Authors are required to disclose commercial or similar relationship to products or compasies mentioned in or related to the subject matter of the article being submitted. Sources of funding for the article should be acknowledged in a footnote on the title page. Affiliations of authors should include corporate appointments relating to or in cnnection with products or companies mentioned in the article, or otherwise bearing on the subject matter thereof. Other pertinent financial relationships, such as consultancies, stock ownership or other equity interests or patent-licensing arrangements, should be disclosed to the Editor-in-Chief in the cover letter at the time of submission. Such relationships may be disclosed in the Journal at the discretion of the Editor-in-Chief in footnotes appearing on the title page. Questions about this policy should be directed to the Editor-in-Chief.
Submission of Manuscripts
Manuscripts must be submitted in scientifically correct English. Articles received that do not comply with this requirement will be returned to the author before being considered for publication. Authors requiring assistance are encouraged to utilize the services of a professional scientific editor. The name of an approved scientific editor can be obtained by calling the Japanese Journal of Ophthalmology editorial office. Content and scientific accuracy of all articles submitted and accepted for publication are the sole responsibility of the author. Manuscripts and all other correspondence should be sent to: Japanese Journal of Ophthalmology, Japanese Ophthalmological Society, 2-4-11-402 Sarugaku-cho, Chiyoda-ku, Tokyo 101, Japan. Phone: 011-81-3-3295-2360, FAX: 011-81-3-3293-9384. Four original manuscripts must be submitted with complete references, tables and figures. Manuscripts should be typewritten, double-spaced with at leat 1" (2.5cm) margins on each side, on one side only of 81/2"×11" (21×29cm) white, bond paper. All pages should be numbered consecutively. On a separate page, list the following information: total number of pages of text (content) , total number of pages of references, total number of pages of illustrations/figures (request for color art) , and total number of pages of tables. Each manuscript should contain the following:
Title page: The title page should contain the article title, full name (s) of author (s) , highest academic degree, department (s) , institution and address, a running title of not more than 40 characters, name, address, email address, and telephone and fax numbers of the corresponding author and acknowledgments.
Abstract: A concise summary of the article that clearly describes the objectives, significant results and conclusions, in no more than 200 words.
Key words: Key words are required for indexing and abstracting services. Up to 10 words may be submitted per manuscript.
Text: Full-length articles and brief communications reporting on research must contain an introduction, materials and methods, results, discussion and conclusions. Abbreviations must be defined immediately following the first use in the text. Unusual abbreviations should be avoided. Drug and chemical names should be staged in standard chemical or generic nomenclature. Units of measure should be presented according to the International System (SI) of units. Clinical data may be presented in conventional units with SI in parenthese.
References: References should be limited to those cited in the text and numbered consecutively as they appear in the text, with their positions indicated in the text. The reference style of the journal is that given in "Uniform Requirements for Manuscripts Submitted t Biomedical Journal" (see JAMA 1993 May 5; 269: 2282-6) . Type the reference section double-spaced at the end of the text, following the examples given below. For abbreviations, refer to List of Journals Indexed in Index Medicus[DHEW Publication No. (NIH) 93-267; ISSN 0093-3821, available from the Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402, USA]. For each reference, provide all authors' names when fewer than seven; when seven or more, list the first three and add et al. Be sure to provide the title of each article and inclusive pages. Accuracy of reference data is the responsibility of the author.
Journal article: 1. Seiler T, Wollensak J. Myopic photorefractive keratectomy with the excimer laser: One-year follow-up. Ophthalmology 1991; 98: 1156-63.
Book: 2. Tolentino FI, Schepens CL, Freeman HM. Vitreoretinal disorders. Philadelphia: Saunders, 1975.
Chapter in Book: 3. Marak GE, Kozak Y, Faure JP. Free radicals and antioxidants in the pathogenesis of eye diseases. In: Emerit I, ed. Antioxidants in therapy and preventive medicine. New York: Plenum Press, 1990: 513-27.
Tables: Tables should be typed on separate pages at the end of the manuscript, cited in order in the text, and numbered consecutively with Arabic numerals. Each table should have a caption typed above the table. Table footnotes should be indicated by superscript lowercase letters.
Figures: Figures must be self-explanatory, cited in order in the text, and numbered consecutively with Arabic numerals. Each Each figure should be titled and the legends should be brief. The title and legend for each figure should be typed on a separate page. The illustrations should be labeled lightly in soft pencil on the back to indicate (a) the top of the figure, (b) the figure number, (c) the author (s) ' name (s) . Figures must be of sufficient size and clarity to allow reduction as necessary to meet layout requirements. Line drawings should be printed on good quality glossy paper. Lettering on micrographs should be clearly legible. Micrographs should be limited to structures specifically discussed in the manuscript. Symbols and areas of special interest should not be close to the edges. Magnification of figures should be given in the legends and on the prints (µm scale) . Symblos used on micrographs should be a minimum of 3 mm in height and explained in the figure legends. Three sets of micrographs, labeled and mounted, are required. All figures must be submitted in a protective envelope. Color figures are welcome, but will be printed at the author's expense. Current rate: $650.00 for one figure on one page; $100.00 for each additional figure on the same page. Author will be billed. Photographs showing face of a subject should be cropped to avoid identification. Photographs of identifiable subjects must be accompanied by signed permission from the patient or a legal representative authorizing publication.
Acknowledgments: If data from another published study are used, it is the author's responsibility to obtain permission and make full acknowledgment. Acknowledgments should be included on a separate page at the end of the text.
Authors are encouraged to submit a 3.5"HD/DD computer disk to the editorial office; 5.25"HD/DD disks are acceptable if 3.5"disks are unavailable. Please observe the following criteria:
1. Send only hard copy when first submitting your paper.
2. When your paper has been reviewed, revised if necessary, and accepted, send a disk containing the final version with the final hard copy. Make sure that the disk and the hard copy match exactly (otherwise the diskette version will prevail) .
3. Specify what software was used, including which release, e.g., WordPerfect 6.0a.
4. Specify what computer was used (IBM-compatible PC, Apple Macintosh, etc.) .
5. The article file should include all textual material (text, references, tables, figure captions, etc.) and separate illustrations files, if available.
6. The file should follow the general instructions on style/arrangements and, in particular, the reference style of this journal as given above.
7. The file should be single-spaced and should use the wraparound end-of-line feature, i.e., returns at the end of paragraphs only. Place two returns after every element such as title, headings, paragraphs, figure and table call-outs.
8. Keep a backup disk for reference and safety.
Pcprints may be ordered prior to publication on the form provided with proofs. The designated reviwing author will be responsible for ordering reprints for all authors. Reprints ordered after publication of the journal can be ordered at increased cost by special arrangement.
Copyright on all published articles will be held by the Japanese Ophthalmological Society.
Expense for Publication
Papers of 4 printed pages or less are published free of charge. For additional printed pages, the authors will be billed $125.00 per page.
Contributions for a RAPID COMMUNICATIONS section will be accepted and we will make every effort to publish these in the subsequent issue after receipt.
The criteria for acceptance of contributions are more stringent that for full papers. RAPID COMMUNICATION should concern novel ideas and findings in new and developing areas of biochemistry that are of special interest or wide applicability. They can be preliminary reports or full accounts of the research involved. They should not exceed 2,500 words in length, including figures, tables and references. If figures or tables cre included, the length of the text must be correspondingly reduced.
Aims and Scope
The Japanese Journal of Ophthalmology, published since 1957, provides a peer-reviewed interdisciplinary forum for bimonthly publication of basic science and clinical research papers in all fields of ophthalmology. The Japanese Ophthalmological Society is dedicated to the preventive care and treatment of the eye, and to scientific research regarding all aspects of ophthalmology. To further these goals, the Society has designated the Japanese Journal of Ophthalmology its official English language publication from January 1997. The purpose of this scientific journal is to disseminate the significant results of study by ophthalmologists worldwide. To help us fulfill our purpose, we encourage you to submit your original papers concerning any area of ophthalmology, as well as Rapid Communications or Letters to the Editor. We welcome your suggestions and criticicism. Japanese Journal of Ophthalmology (ISSN 0021-5155) is published bimonthly by Elsevier Science Inc., 655 Avenue of the Americas, New York, NY 10010-5167, USA.
Manuscript submissions should be addressed to: Japanese Journal of Ophthalmology, Japanese ophthalmological Society, 2-4-11-402 Sarugaku-cho, Chiyoda-ku, Tokyo 101, Japan, Phone: 011-81-3-3295-2360, Fax: 011-81-3-3293-9384.
No responsibility is assumed by the publisher or the Japanese Ophthalmological Society for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instruction, or ides contained in the material herein. No test or procedures sholld be carried out unless in the reader's judgment, its risk is justified. Because of rapid advances in the medical sciences, we recommend that the independent verification of diagnoses and drug dosages should be made. Discussions, views and recommendations as to medical procedures, choice of drugs and durg dosages are the responsibility of the authors. Although all advertising material in the Japanese Journal of Ophthalmology is expected to conform to ethical (medial) standards, the inclusion in this publication does not constitute a guarantee or endorsemen by the publisher of the quality or value of such product or of the claim made of it by its ranufacturer.
Advertising inquiries should addressed to Gene Conselyea, Elsevier Science Inc., 655 Avenue of the Americas, Now York, NY 10010-5107; phone (212) 633-3686; fax (212) 633-3820.
Reprint inquiries should be addressed to Dan Cronin, Elsevier Science Inc., 655 Avenue of the Americas, New York, NY 10010-5107; phone (212) 633-3813; fax (212) 633-8320.
This journal and the individual contributions contained in it are protected by the copyright of the Japases Ophthalmological Society and the following terms and conditions apply to their use:
Photocopying: Single photocopies of single articles may be made for personal use as allowed by national copyright laws. Permission of the Publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying, for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational institutions that wish to make photocopies for nonprofit educational classroom use. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923; telephone (508) 750-8400. In the UK, users may clear permissions and make payment through the Copyright Licensing Agency Rapid Clearance Service (CLARCS) . In other countries where a local copyright clearance center exists, please contact it for information on required permissions and payments.
All inquiries regarding copyright material from this publication, other than reproduction through the Copyright Clearance Center, should be directed to Rights and Permissions Department, Elsevier Science Inc., 655 Avenue of the Americas, New York, NY 10010-5107. Telephone: (212) 633-3697; Fax: (212) 633-3977.